While these drugs offer significant preoperative weight loss benefits, their impact on surgical outcomes, tissue healing, and perioperative complications remains unclear
Health Canada is advising patients to consult their doctor before stopping the use of the recalled drugs or for any health concerns
At 24 weeks, retatrutide 12 mg delivers 17.5% body weight loss versus an estimated 12-13% for tirzepatide 15 mg
Each plan covers the medication, physician consultation through Beluga Health's board-certified network across all 50 states, preparation at F&F Pharmacies Inc., shipping, and platform access
Furthermore, typical side effects associated with the use of such drugs, including nausea and digestion problems, have resulted in an increased interest of consumers in products that do not cause discomfort and which are easily digestible, low on sugar and with controlled portions